Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ARMS2, ALA69SER

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Clinical and genetic characteristics of pachydrusen in patients with exudative age-related macular degeneration
We investigated the clinical and genetic characteristics of patients with unilateral exudative age-related macular degeneration… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2017
2017
Pachychoroid Geographic Atrophy: Clinical and Genetic Characteristics.
PURPOSE To describe the clinical and genetic characteristics of pachychoroid geographic atrophy (GA) and to compare them with… Expand
Is this relevant?
2017
2017
Comparison of two-year outcomes after photodynamic therapy with ranibizumab or aflibercept for polypoidal choroidal vasculopathy
Photodynamic therapy (PDT) combined with intravitreal anti-vascular endothelial growth factor (VEGF) agents is currently the… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2017
2017
Prevalence and characteristics of pseudodrusen subtypes in advanced age-related macular degeneration
PurposeThe purpose of our study was to investigate the clinical and genetic characteristics of pseudodrusen subtypes and their… Expand
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2017
2017
Retreatment of Exudative Age-Related Macular Degeneration after Loading 3-Monthly Intravitreal Ranibizumab
Purpose: The aim of this study was to investigate the clinical implications of required retreatment after 3-monthly intravitreal… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2016
2016
GENETIC FACTORS ASSOCIATED WITH CHOROIDAL VASCULAR HYPERPERMEABILITY AND SUBFOVEAL CHOROIDAL THICKNESS IN POLYPOIDAL CHOROIDAL VASCULOPATHY.
PURPOSE To investigate genetic factors associated with choroidal vascular hyperpermeability (CVH) and subfoveal choroidal… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2016
2016
Risk Factors for Second Eye Involvement in Eyes with Unilateral Polypoidal Choroidal Vasculopathy
Abstract Purpose: To investigate risk factors associated with developing polypoidal choroidal vasculopathy (PCV) lesions in the… Expand
Is this relevant?
2014
2014
Genetic Variants in the SKIV2L Gene in Exudative Age-related Macular Degeneration in the Japanese Population
Abstract Background: To investigate whether genetic variant in superkiller viralicidic activity 2-like (SKIV2L) gene is… Expand
Is this relevant?
2011
2011
Role of complement factor H I62V and age-related maculopathy susceptibility 2 A69S variants in the clinical expression of polypoidal choroidal vasculopathy.
PURPOSE To investigate the role of complement factor H (CFH) I62V (rs800292) and age-related maculopathy susceptibility 2 (ARMS2… Expand
Is this relevant?
2011
2011
Difference between age-related macular degeneration and polypoidal choroidal vasculopathy in the hereditary contribution of the A69S variant of the age-related maculopathy susceptibility 2 gene…
Purpose To investigate whether the A69S variant of the age-related maculopathy susceptibility 2 gene (ARMS2) has a different… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE